Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium

Clinical trial NCT04008121 · RECRUITING

Trial details

NCT number: NCT04008121
Sponsor: MediBeacon
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Retinopathy Retinal Vein Occlusion Diabetic Retinopathy Macular Degeneration

Start date: 2025-11-06
Primary completion: 2026-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.